Market revenue in 2023 | USD 134.3 million |
Market revenue in 2030 | USD 194.8 million |
Growth rate | 5.5% (CAGR from 2023 to 2030) |
Largest segment | Purity>98% |
Fastest growing segment | Purity>98% |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Purity>98%, Purity<98% |
Key market players worldwide | Merck KGaA, GSK PLC, Cipla Ltd DR, Novartis AG ADR, Sanofi SA, Aurobindo Pharma, Teva Pharmaceutical Industries Ltd, Mallinckrodt PLC Ordinary Shares - New, Cayman Chemical, Tokyo Chemical Industry, APExBIO Technology, Wilshire Technologies, Biosynth |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to crocin market will help companies and investors design strategic landscapes.
Purity>98% was the largest segment with a revenue share of 95.53% in 2023. Horizon Databook has segmented the Japan crocin market based on purity>98%, purity<98% covering the revenue growth of each sub-segment from 2018 to 2030.
Japan has strict rules pertaining to medicines. Even when it comes to OTC medications, Japan has strict medical regulations. Several medicines available in the U.S. and other countries worldwide are illegal in Japan.
The Japanese government allows the import of paracetamol and general OTC medicines for a 2- month supply, while prescription medications are only for a 1-month supply. Japan has a large geriatric population, which is at high risk of infectious and other diseases that need pain management solutions.
According to the World Bank, in 2022, around 37.44 individuals belonged to the age group of 65 years and above. An increase in R&D on innovative products to offer optimal healthcare and pain management solutions to improve a patient’s overall quality of life is among the key factors contributing to market growth in Japan.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan crocin market , including forecasts for subscribers. This country databook contains high-level insights into Japan crocin market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account